Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer

scientific article

Interleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11507072

P2093author name stringKawakami M
Kawakami K
Puri RK
Joshi BH
P433issue16
P407language of work or nameEnglishQ1860
P921main subjectinterleukinsQ194908
P304page(s)6194-6200
P577publication date2001-08-01
P1433published inCancer ResearchQ326097
P1476titleInterleukin-13 receptor-targeted cancer therapy in an immunodeficient animal model of human head and neck cancer
P478volume61

Reverse relations

cites work (P2860)
Q36108466Affitoxin--a novel recombinant, HER2-specific, anticancer agent for targeted therapy of HER2-positive tumors
Q37970682Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment
Q36295853Chemopreventive and chemotherapeutic actions of mTOR inhibitor in genetically defined head and neck squamous cell carcinoma mouse model.
Q37390393Effect of treatment on systemic cytokines in head and neck squamous cell carcinoma patients
Q35847498Hodgkin lymphoma therapy with interleukin-4 receptor-directed cytotoxin in an infiltrating animal model
Q36545018IL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice
Q36926747Identification of interleukin-13 receptor alpha2 chain overexpression in situ in high-grade diffusely infiltrative pediatric brainstem glioma
Q36369794In vivo overexpression of IL-13 receptor alpha2 chain inhibits tumorigenicity of human breast and pancreatic tumors in immunodeficient mice
Q35789233Interleukin-13 fusion cytotoxin arrests Schistosoma mansoni egg-induced pulmonary granuloma formation in mice
Q90195010Interleukin4Rα (IL4Rα) and IL13Rα1 Are Associated with the Progress of Renal Cell Carcinoma through Janus Kinase 2 (JAK2)/Forkhead Box O3 (FOXO3) Pathways
Q36863089MicroRNA-135b acts as a tumor promoter by targeting the hypoxia-inducible factor pathway in genetically defined mouse model of head and neck squamous cell carcinoma
Q28571784Molecular cloning of the rat IL-13 alpha 2 receptor cDNA and its expression in rat tissues
Q26850237Nucleic acid targeting: towards personalized therapy for head and neck cancer.
Q37078999Prioritization schema for immunotherapy clinical trials in glioblastoma
Q36686360Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling
Q33525571Therapeutic efficacy of Cintredekin Besudotox (IL13-PE38QQR) in murine lung fibrosis is unaffected by immunity to Pseudomonas aeruginosa exotoxin A.
Q35942450Therapeutic targeting of IL-4- and IL-13-responsive cells in pulmonary fibrosis
Q27006226Toxin-based targeted therapy for malignant brain tumors
Q48303412Tumor targeted delivery of doxorubicin in malignant peripheral nerve sheath tumors.

Search more.